Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7264)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2014 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hu KC, Wang HY, Liu SC, Liu CC, Hung CL, Bair MJ, Liu CJ, Wu MS, Shih SC. Nonalcoholic fatty liver disease: Updates in noninvasive diagnosis and correlation with cardiovascular disease. World J Gastroenterol 2014; 20(24): 7718-7729 [PMID: 24976709 DOI: 10.3748/wjg.v20.i24.7718] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i24/7718.htm |
| Number | Citing Articles |
| 1 |
Khalid A. Alsuhaibani, Faris S. Althunayyan, Ali M. Alsudays, Ahmad A. Alharbi, Badr M. Aljarallah. Nonalcoholic fatty liver disease in lean and obese patients in Saudi patients from a single center. Journal of Family Medicine and Primary Care 2021; 10(9): 3381 doi: 10.4103/jfmpc.jfmpc_185_21
|
| 2 |
Hyunsoo Chung, Young Eun Chon, Seung Up Kim, Sang Kil Lee, Kyu Sik Jung, Kwang-Hyub Han, Chae Yoon Chon. Noninvasive Prediction of Erosive Esophagitis Using a Controlled Attenuation Parameter (CAP)-Based Risk Estimation Model. Digestive Diseases and Sciences 2016; 61(2): 507 doi: 10.1007/s10620-015-3902-7
|
| 3 |
Josep Marí-Alexandre, Moises Barceló-Molina, Jorge Sanz-Sánchez, Pilar Molina, Jennifer Sancho, Yolanda Abellán, María Luisa Santaolaria-Ayora, Juan Giner, Luis Martínez-Dolz, Amparo Estelles, Aitana Braza-Boïls, Esther Zorio. El grosor y una expresión de miARN alterada en la grasa epicárdica se asocian con enfermedad coronaria en víctimas de muerte súbita. Revista Española de Cardiología 2019; 72(1): 30 doi: 10.1016/j.recesp.2017.12.003
|
| 4 |
ZHOU ZHOU, YING-CHAO LIU, XIAO-MEI CHEN, FU-QIANG LI, XIAO-JUAN TONG, YUE-PING DING, CUI-LAN TANG. Treatment of experimental non-alcoholic steatohepatitis by targeting α7 nicotinic acetylcholine receptor-mediated inflammatory responses in mice. Molecular Medicine Reports 2015; 12(5): 6925 doi: 10.3892/mmr.2015.4318
|
| 5 |
Yun Qiu, Sufan Wang, Ting Wan, Mingtong Ye, Rui Jiang, Lei Pei, Lili Yang. Blood-Based Novel Biomarkers for Nonalcoholic Steatohepatitis. Biomarkers in Medicine 2018; 12(5): 501 doi: 10.2217/bmm-2017-0361
|
| 6 |
Huanqiu Wang, Ruyu Sun, Sisi Yang, Xueqing Ma, Chengbo Yu. Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.934989
|
| 7 |
A. Mojtahed, C. J. Kelly, A. H. Herlihy, S. Kin, H. R. Wilman, A. McKay, M. Kelly, M. Milanesi, S. Neubauer, E. L. Thomas, J. D. Bell, R. Banerjee, M. Harisinghani. Reference range of liver corrected T1 values in a population at low risk for fatty liver disease—a UK Biobank sub-study, with an appendix of interesting cases. Abdominal Radiology 2019; 44(1): 72 doi: 10.1007/s00261-018-1701-2
|
| 8 |
Rodrigo Bremer Nones, Cláudia Pontes Ivantes, Maria Lucia Alves Pedroso. Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?. Archives of Endocrinology and Metabolism 2017; 61(3): 276 doi: 10.1590/2359-3997000000233
|
| 9 |
Yong Jiang, Tao Han, Zhi-Guang Zhang, Ying Zhang, Feng-Xiang Qi. Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis. Revista Española de Enfermedades Digestivas 2017; 110 doi: 10.17235/reed.2017.4690/2016
|
| 10 |
Pengzi Zhang, Wenhuan Feng, Xuehui Chu, Xitai Sun, Dalong Zhu, Yan Bi. A newly noninvasive model for prediction of non-alcoholic fatty liver disease: utility of serum prolactin levels. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1120-z
|
| 11 |
Ying-Chun Lin, Horng-Yuan Wang, Yang-Che Kuo, Ming-Jen Chen, Ming-Shiang Wu, Chun-Jen Liu, Horng Woei Yang, Shou-Chuan Shih, Lo-Yip Yu, Hung-Ju Ko, Hung-I Yeh, Kuang-Chun Hu. Gut-flora metabolites is not associated with synchronous carotid artery plaque and non-alcoholic fatty liver disease in asymptomatic adults. Medicine 2021; 100(34): e27048 doi: 10.1097/MD.0000000000027048
|
| 12 |
Chia-Chu Chang, Chia-Lin Wu, Wei-Wen Su, Kai-Lun Shih, Der-Cherng Tarng, Chen-Te Chou, Ting-Yu Chen, Chew-Teng Kor, Hung-Ming Wu. Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease. Scientific Reports 2015; 5(1) doi: 10.1038/srep10096
|
| 13 |
Benjamin Renelus, Temitope Foster. Noninvasive evaluation of nonalcoholic fatty liver disease. Clinical Liver Disease 2016; 7(3): 45 doi: 10.1002/cld.538
|
| 14 |
Hedayat Allah Shahmohammadi, Seyed Ahmad Hosseini, Eskandar Hajiani, Amal Saki Malehi, Meysam Alipour. Effects of Green Coffee Bean Extract Supplementation on Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial. Hepatitis Monthly 2017; 17(4) doi: 10.5812/hepatmon.45609
|
| 15 |
Zohreh Sadat Sangsefidi, Mahdieh Hosseinzadeh, Ali Mohammad Ranjbar, Mohsen Akhondi-Meybodi, Hossein Fallahzadeh, Hassan Mozaffari-Khosravi. The effect of total anthocyanin-base standardized (Cornus mas L.) fruit extract on liver function, tumor necrosis factor α, malondealdehyde, and adiponectin in patients with non-alcoholic fatty liver: a study protocol for a double-blind randomized clinical trial. Nutrition Journal 2019; 18(1) doi: 10.1186/s12937-019-0465-z
|
| 16 |
Tasur Kumar Seen, Muntazir Sayed, Muhammad Bilal, Jonathan Vincent Reyes, Priyanka Bhandari, Vennis Lourdusamy, Ahmed Al-khazraji, Umer Syed, Yasar Sattar, Raghav Bansal. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis. World Journal of Gastroenterology 2021; 27(23): 3238-3248 doi: 10.3748/wjg.v27.i23.3238
|
| 17 |
Josep Marí-Alexandre, Moises Barceló-Molina, Jorge Sanz-Sánchez, Pilar Molina, Jennifer Sancho, Yolanda Abellán, María Luisa Santaolaria-Ayora, Juan Giner, Luis Martínez-Dolz, Amparo Estelles, Aitana Braza-Boïls, Esther Zorio. Thickness and an Altered miRNA Expression in the Epicardial Adipose Tissue Is Associated With Coronary Heart Disease in Sudden Death Victims. Revista Española de Cardiología (English Edition) 2019; 72(1): 30 doi: 10.1016/j.rec.2017.12.007
|
| 18 |
Venkatanarayana Gangarapu, Ali Tüzün Ince, Birol Baysal, Yusuf Kayar, Ulkan Klç, Özlem Gök, Ömer Uysal, Hakan Şenturk. Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2015; 27(7): 840 doi: 10.1097/MEG.0000000000000348
|
| 19 |
S. V. Okovity, K. L. Raikhelson, A. V. Volnukhin, D. A. Kudlai. Hepatoprotective properties of glycyrrhizic acid. Experimental and Clinical Gastroenterology 2020; (12): 96 doi: 10.31146/1682-8658-ecg-184-12-96-108
|
| 20 |
Kamal K. Mahawar, Chetan Parmar, Yitka Graham, Ayman Abouleid, William R. J. Carr, Neil Jennings, Norbert Schroeder, Peter K. Small. Routine Liver Biopsy During Bariatric Surgery: an Analysis of Evidence Base. Obesity Surgery 2016; 26(1): 177 doi: 10.1007/s11695-015-1916-z
|
| 21 |
Pegah Golabi, Mehmet Sayiner, Yousef Fazel, Aaron Koenig, Linda Henry, Zobair M Younossi. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis. Expert Review of Gastroenterology & Hepatology 2016; 10(1): 63 doi: 10.1586/17474124.2016.1099433
|
| 22 |
Lennard Wolff, Daniel Bos, Sarwa Darwish Murad, Oscar H. Franco, Gabriel P. Krestin, Albert Hofman, Meike W. Vernooij, Aad van der Lugt. Liver fat is related to cardiovascular risk factors and subclinical vascular disease: the Rotterdam Study. European Heart Journal – Cardiovascular Imaging 2016; 17(12): 1361 doi: 10.1093/ehjci/jew174
|
| 23 |
Oya Balcı Sezer, Derya Buluş, Şamil Hızlı, Nesibe Andıran, Deniz Yılmaz, Selma Uysal Ramadan. Low 25-hydroxyvitamin D level is not an independent risk factor for hepatosteatosis in obese children. Journal of Pediatric Endocrinology and Metabolism 2016; 29(7) doi: 10.1515/jpem-2015-0426
|